Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthofix Medical (OFIX) Profit After Tax (2016 - 2026)

Orthofix Medical has reported Profit After Tax over the past 17 years, most recently at -$20.9 million for Q1 2026.

  • For the quarter ending Q1 2026, Profit After Tax rose 60.62% year-over-year to -$20.9 million, compared with a TTM value of -$60.0 million through Mar 2026, up 58.06%, and an annual FY2025 reading of -$92.2 million, up 26.83% over the prior year.
  • Profit After Tax came in at -$20.9 million for Q1 2026, down from -$2.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $2.5 million in Q2 2022 to a low of -$60.9 million in Q1 2023.
  • Median Profit After Tax over the past 5 years was -$22.8 million (2025), compared with a mean of -$24.1 million.
  • The sharpest move saw Profit After Tax tumbled 1684.01% in 2023, then skyrocketed 92.38% in 2025.
  • Over 5 years, Profit After Tax stood at -$7.1 million in 2022, then plummeted by 213.99% to -$22.2 million in 2023, then plummeted by 31.44% to -$29.1 million in 2024, then skyrocketed by 92.38% to -$2.2 million in 2025, then plummeted by 840.95% to -$20.9 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Profit After Tax are -$20.9 million (Q1 2026), -$2.2 million (Q4 2025), and -$22.8 million (Q3 2025).